CCI Welcomes NanoTess as the Newest Member of our National Network

The Council of Canadian Innovators is proud to welcome Calgary-based NanoTess and CEO Megan Leslie as the newest member of our national network of high-growth technology companies.

NanoTess is changing how we treat difficult wounds and persistent skin conditions. Their advanced catalytic technology, NanoSALV Catalytic, supports the body’s natural healing process. It is already helping people across Canada recover when traditional treatments were unsuccessful, improving care, reducing pressure on families, and easing demand on the health system.

CEO Megan Leslie has guided the company through major milestones, including partnerships with hospitals, health networks, and national distributors. With a background in engineering, finance, and people-focused design, she has helped make NanoTess one of the most promising biotech companies in the country.

"NanoTess is a powerful example of what Canadian innovation can do," said CCI President Benjamin Bergen. "They are improving health outcomes, building domestic capacity, and showing that Canadian companies can lead in medical technology."

If you would like to learn more about how NanoTess is healing people from persistent eczema to chronic wounds, learn more here.

Since 2015, the Council of Canadian Innovators has been the business voice for high-growth technology companies, working closely with government leaders to develop policies that strengthen Canada’s innovation economy.